EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation

Melanie A Gunawardene, Gerrit Frommeyer iD, Christian Ellermann, Mario Jularic, Patrick Leitz, Jens Hartmann, Philipp Sebastian Lange, Omar Anwar iD, Benjamin Rath, Rahin Wahedi, Lars Eckardt iD, Stephan Willems

Journal of Clinical Medicine · 29.09.2023 · 12 (19) · 6304

DOI: 10.3390/jcm12196304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.09.2023. Verfasst von Melanie A Gunawardene und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Intensive Care Medicine, Asklepios Hospital St. Georg, 20099 Hamburg, Germany. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Left atrial posterior wall isolation (LAPWI) may improve rhythm control in addition to pulmonary vein isolation (PVI) in persistent atrial fibrillation (persAF) patients undergoing catheter ablation (CA). However, LAPWI may be challenging when using thermal energy sources.

Objective

This study aimed to investigate the efficacy and safety of LAPWI performed by non-thermal pulsed field ablation (PFA) in CA for persAF.

Methods

Consecutive persAF patients from two German centers were prospectively enrolled. There were two study cohorts: (1) the LAPWI cohort, which included PFA-guided (re-)PVI with LAPWI for first-time and/or repeat ablation procedures; and (2) a comparative persAF cohort with a PFA PVI-only approach without LAPWI for first-time ablation within the same timeframe. Patients were followed up by routine Holter ECGs.

Results

In total, 79 persistent AF patients were included in the study: 59/79 patients were enrolled in the LAPWI cohort, including 16/59 index (27%) and 43/59 repeat ablation procedures (73%). Sixteen patients (16/79; 21%) were in the PVI-only cohort without LAPWI. Of the patients treated with LAPWI, procedure time and fluoroscopy time was 91 ± 30 min and 15 ± 7 min, respectively. The acute PVI rate was 100% in all first-time ablation patients (32 patients (16 PVI only, 16 PVI plus LAPWI), 196/196 PVs). Of the 43 re-do patients in the LAPWI cohort, re-PVI was necessary in 33% (14/43) of patients (27 PVs; 1.9 PV per-patient); in 67% (29/43), all PVs were isolated, and antral ablation of the PV ostia was performed in 48% (14/29). LAPWI was performed successfully in all 59 (100%) patients of the LAPWI cohort. Two minor complications occurred. No esophageal lesion was detected in the LAPWI cohort (n = 33/59 (56%) patients underwent endoscopy). After 354 ± 197 days of follow-up, freedom from atrial arrhythmias was 79.3% (95-CI: 62–95%) in the complete LAPWI cohort (n = 14/59 (24%) on AAD: class Ic n = 9, class III n = 5). There was no difference regarding acute procedural and clinical outcome compared to the PVI-only cohort.

Conclusion

LAPWI guided by PFA is feasible and safe in patients undergoing CA for persAF and shows favorable outcomes. In the context of durable PVI, PFA-guided LAPWI may be an effective adjunctive treatment option.

Schlagwörter

Stichwörter der Autor:innen

left atrial posterior wall isolationpersistent atrial fibrillationpulmonary vein isolationpulsed field ablation

Autor:innen und Institutionen

  • Department of Cardiology and Intensive Care Medicine, Asklepios Hospital St. Georg, 20099 Hamburg, Germany.
  • Semmelweis University, 1082 Budapest, Hungary.
  • DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 10178 Berlin, Germany.
  • Division of Electrophysiology, Department of Cardiovascular Medicine, University of Münster, 48149 Münster, Germany.

ORCID-Profile: Gerrit Frommeyer, Omar Anwar, Lars Eckardt

Zitieren

APA

Gunawardene, M. A., Frommeyer, G., Ellermann, C., Jularic, M., Leitz, P., Hartmann, J., Lange, P. S., Anwar, O., Rath, B., Wahedi, R., Eckardt, L., & Willems, S. (2023). Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation. Journal of Clinical Medicine, 12(19), 6304. https://doi.org/10.3390/jcm12196304

Vancouver

Gunawardene MA, Frommeyer G, Ellermann C, Jularic M, Leitz P, Hartmann J, et al. Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation. Journal of Clinical Medicine. 2023;12(19):6304. doi:10.3390/jcm12196304

BibTeX
@article{Gunawardene2023,
  author = {Gunawardene, Melanie A and Frommeyer, Gerrit and Ellermann, Christian and Jularic, Mario and Leitz, Patrick and Hartmann, Jens and Lange, Philipp Sebastian and Anwar, Omar and Rath, Benjamin and Wahedi, Rahin and Eckardt, Lars and Willems, Stephan},
  title = {Left Atrial Posterior Wall Isolation with Pulsed Field Ablation in Persistent Atrial Fibrillation},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {19},
  pages = {6304},
  doi = {10.3390/jcm12196304}
}
Kostenlos starten →